Ann Lab Med.  2021 Mar;41(2):214-220. 10.3343/alm.2021.41.2.214.

Performance Evaluation of VITEK MS for the Identification of a Wide Spectrum of Clinically Relevant Filamentous Fungi Using a Korean Collection

• Shin JH
• Kim SH
• Lee D
• Lee SY
• Chun S
• Lee JH
• Won EJ
• Choi HJ
• Choi HW
• Kee SJ
• Shin MG
• Shin JH

• KMID: 2512668
• DOI: http://doi.org/10.3343/alm.2021.41.2.214

Abstract

The correct identification of filamentous fungi is challenging. We evaluated the performance of the VITEK MS v3.0 system (bioMérieux, Marcy-l’Étoile, France) for the identification of a wide spectrum of clinically relevant filamentous fungi using a Korean collection. Strains that were added to the upgraded v3.2 database were additionally identified by the VITEK MS v3.2 system. Of the 105 tested isolates, including 37 Aspergillus (nine species), 41 dermatophytes (seven species), and 27 other molds (17 species), 43 (41.0%) showed “no identification” or “multiple species identification” results at the initial VITEK MS testing; these isolates were retested using the same method. Compared with sequence-based identification, the correct identification rate using VITEK MS for Aspergillus, dermatophytes, other molds, and total mold isolates was 67.6%, 56.1%, 48.1%, and 58.1% at the initial testing and 94.6%, 78.0%, 55.6%, and 78.1% with retesting, respectively. Following retesting, 19 (18.1%) and two (1.9%) isolates showed “no identification” and “misidentification” results, respectively. VITEK MS reliably identified various filamentous fungi recovered in Korea, with a very low rate of misidentification

Keyword

Filamentous fungi; Mass spectrometry; VITEK MS; Aspergillus; Dermatophytes; Performance; Identification

Reference

1. Enoch DA, Ludlam HA, Brown NM. 2006; Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol. 55:809–18. DOI: 10.1099/jmm.0.46548-0. PMID: 16772406.

2. Benedict K, Richardson M, Vallabhaneni S, Jackson BR, Chiller T. 2017; Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks. Lancet Infect Dis. 17:e403–11.

3. Bongomin F, Gago S, Oladele RO, Denning DW. 2017; Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi (Basel). 3:E57.

4. Wickes BL, Wiederhold NP. 2018; Molecular diagnostics in medical mycology. Nat Commun. 9:5135. DOI: 10.1038/s41467-018-07556-5. PMID: 30510235. PMCID: PMC6277409.

5. Kozel TR, Wickes B. 2014; Fungal diagnostics. Cold Spring Harb Perspect Med. 4:a019299. DOI: 10.1101/cshperspect.a019299. PMID: 24692193. PMCID: PMC3968782.

6. Dupont D, Normand AC, Persat F, Hendrickx M, Piarroux R, Wallon M. 2019; Comparison of matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of moulds in the routine microbiology laboratory. Clin Microbiol Infect. 25:892–7. DOI: 10.1016/j.cmi.2018.10.013. PMID: 30394360.

7. Rychert J, Slechta ES, Barker AP, Miranda E, Babady NE, Tang YW, et al. 2018; Multicenter evaluation of the Vitek MS v3.0 system for the identification of filamentous fungi. J Clin Microbiol. 56:e01353–17. DOI: 10.1128/JCM.01353-17. PMID: 29142047. PMCID: PMC5786734.

8. McMullen AR, Wallace MA, Pincus DH, Wilkey K, Burnham CA. 2016; Evaluation of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of clinically relevant filamentous fungi. J Clin Microbiol. 54:2068–73. DOI: 10.1128/JCM.00825-16. PMID: 27225405. PMCID: PMC4963483.

9. Sanguinetti M, Posteraro B. 2017; Identification of molds by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 55:369–79. DOI: 10.1128/JCM.01640-16. PMID: 27807151. PMCID: PMC5277505.

10. Park JH, Shin JH, Choi MJ, Choi JU, Park YJ, Jang SJ, et al. 2017; Evaluation of matrix-assisted laser desorption/ionization time-of-fight mass spectrometry for identification of 345 clinical isolates of Aspergillus species from 11 Korean hospitals: comparison with molecular identification. Diagn Microbiol Infect Dis. 87:28–31. DOI: 10.1016/j.diagmicrobio.2016.10.012. PMID: 28336134.

11. Petti CA. 2007; Detection and identification of microorganisms by gene amplification and sequencing. Clin Infect Dis. 44:1108–14. DOI: 10.1086/512818. PMID: 17366460.

12. van Belkum A, Welker M, Pincus D, Charrier JP, Girard V. 2017; Matrix-assisted laser desorption ionization time-of-flight mass spectrometry in clinical microbiology: what are the current issues? Ann Lab Med. 37:475–83.

13. Heo MS, Shin JH, Choi MJ, Park YJ, Lee HS, Koo SH, et al. 2015; Molecular identification and amphotericin B susceptibility testing of clinical isolates of Aspergillus from 11 hospitals in Korea. Ann Lab Med. 35:602–10. DOI: 10.3343/alm.2015.35.6.602. PMID: 26354348. PMCID: PMC4579104.

14. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, Mellado E, Rodríguez-Tudela JL. 2008; Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother. 61:805–9. DOI: 10.1093/jac/dkn022. PMID: 18263569.

15. Kim SL, Lee KC, Jang YH, Lee SJ, Kim do W, Lee WJ, et al. 2016; The epidemiology of dermatophyte infection in southeastern Korea (1979~2013). Ann Dermatol. 28:524–7. DOI: 10.5021/ad.2016.28.4.524. PMID: 27489448. PMCID: PMC4969495.

16. Guevara-Suarez M, Sutton DA, Cano-Lira JF, García D, Martin-Vicente A, Wiederhold N, et al. 2016; Identification and antifungal susceptibility of Penicillium-like fungi from clinical samples in the United States. J Clin Microbiol. 54:2155–61. DOI: 10.1128/JCM.00960-16. PMID: 27280422. PMCID: PMC4963513.

17. Sandoval-Denis M, Sutton DA, Martin-Vicente A, Cano-Lira JF, Wiederhold N, Guarro J, et al. 2015; Cladosporium species recovered from clinical samples in the United States. J Clin Microbiol. 53:2990–3000. DOI: 10.1128/JCM.01482-15. PMID: 26179305. PMCID: PMC4540897.